ENTRY       D10577            Mixture   Drug
NAME        Ceftolozane sulfate and tazobactam sodium;
            Zerbaxa (TN)
  ABBR      C/T
PRODUCT     ZERBAXA (Merck Sharp & Dohme LLC)
COMPONENT   Ceftolozane sulfate [DR:D10098], Tazobactam sodium [DR:D03707]
REMARK      Therapeutic category: 6139
            ATC code: J01DI54
            Product: D10577<JP/US>
EFFICACY    Antibacterial
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J01 ANTIBACTERIALS FOR SYSTEMIC USE
               J01D OTHER BETA-LACTAM ANTIBACTERIALS
                J01DI Other cephalosporins and penems
                 J01DI54 Ceftolozane and beta-lactamase inhibitor
                  D10577  Ceftolozane sulfate and tazobactam sodium &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antibacterials
              Beta-lactam, Cephalosporins
               Ceftolozane Sulfate/ Tazobactam
                D10577  Ceftolozane sulfate and tazobactam sodium
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              61  Antibiotics
               613  Acting mainly on gram-positive and gram-negative bacteria
                6139  Others
                 D10577  Ceftolozane sulfate and tazobactam sodium
            Antimicrobials [BR:br08307]
             Antibacterials
              Cell wall biosynthesis inhibitor, beta-lactam
               Other cephalosporin
                D10577  Ceftolozane sulfate and tazobactam sodium &lt;JP/US&gt;
            Antimicrobials abbreviations [BR:br08327]
             Antibacterials
              Cell wall biosynthesis inhibitor, beta-lactam
               Other cephalosporin
                D10577  Ceftolozane sulfate and tazobactam sodium
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10577
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10577
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10577
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10577
DBLINKS     PubChem: 254741539
            ChEBI: 85191
///
